A Protocol To Characterize Peptide-Based Drug Delivery Systems for miRNAs

[Image: see text] Micro RNA (miRNA)-based medicines have attracted attention as new therapeutic strategies to treat genetic diseases and metabolic and immunological disorders. MiRNAs have emerged as key mediators of metabolic processes fulfilling regulatory functions in maintaining physiological con...

Descripción completa

Detalles Bibliográficos
Autores principales: Schachner-Nedherer, Anna-Laurence, Werzer, Oliver, Zimmer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648615/
https://www.ncbi.nlm.nih.gov/pubmed/31459813
http://dx.doi.org/10.1021/acsomega.8b03562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648615/
https://www.ncbi.nlm.nih.gov/pubmed/31459813
http://dx.doi.org/10.1021/acsomega.8b03562

Ejemplares similares